PD-L1 (Programmed death receptor ligand 1) also designated as B7-H1 or CD274, is a B7 related protein belonging to the BTN/MOG family. It is a 40 kDa type I transmembrane protein that binds to its receptor, PD-1, found on CD4 and CD8 thymocytes, activated T and B lymphocytes and myeloid cells. As a result of this interaction, T-cell receptor (TCR)-mediated proliferation is attenuated and an active immune response is prevented. This mechanism is often co-opted by tumors and is thought to play an important role in tumor immune evasion. It is expressed on T lymphocytes, NK cells, B lymphocytes, dendritic cells, as well as IFNγ stimulated monocytes, epithelial cells, and endothelial cells. PD-L1 is expressed in several tumor types, including melanoma, breast, ovary, colon, lung, and renal cell carcinomas.
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | PDL1/2746 |
| Source | Mouse |
| Tissue Type/Cancer Type | Heart Tissue |
| Pack | 6 mL – Manual – RTU, 100 Tests – Automation – i6000, 1 mL – Manual – Concentrate, 0.5 mL – Manual – Concentrate, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP®, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
